The Role of Blood Fibrinolytic Factor Plasmin Activity in Manipulating Macrophage-mediated Mechanisms of Atherosclerosis Promotion
Description: In this study, we analyzed the effect of plasminogen (Plg) on the development of atherosclerosis in mice double-deficient (Ldlr-/-/Apobec1-/-) in the LDL receptor and RNA-editing enzyme APOBEC1, a mouse model of human type IIa familial hyperlipidemia, the most common form of hyperlipidemia in humans. Plg did not affect the expression of scavenger receptors involved in LDL uptake by Mφ, suggesting a novel pathogenetic mechanism that controls Mφ atherosclerosis progression by directly regulating LDL size.
Amount: ¥4,160,000
Funding type: fellowship
Funder scheme: Grant-in-Aid for Early-Career Scientists
Start date: 2018-04-01
End date: 2022-03-31
Investigator: Chiharu Miyajima (lead)
Institutions: Hamamatsu University School of Medicine, Nagoya City University, Nagoya City University(2019-2021)Hamamatsu University School of Medicine(2018)
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Funded outputs count: 9
Funder award ID: 18K16081
OpenAlex ID: G6313367657
